Skip to main content

Jennifer Brigitte Green

Professor of Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
Duke Box 3850, Durham, NC 27715
Durham Centre, Room 641, P.O. Box 17969, Durham, NC 27715

Overview


Diabetes Mellitus: Prevention strategies, predictors, treatment effects; kidney and other complications including cardiovascular outcomes. Utilization of EHR data to construct tools to improve the care of diabetes and comorbid conditions.

Current Appointments & Affiliations


Professor of Medicine · 2021 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine
Member in the Duke Clinical Research Institute · 2008 - Present Duke Clinical Research Institute, Institutes and Centers

In the News


Published November 2, 2022
Five Common Myths About Diabetes

View All News

Recent Publications


Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective.

Journal Article Am Heart J · August 2025 Cardiovascular disease remains the leading cause of mortality and healthcare expenditures in the United States. It is also a major contributor to premature mortality, years lived with disability, and rising healthcare costs around the world. Despite the av ... Full text Link to item Cite

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Journal Article Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · May 2025 Patients with chronic kidney disease (CKD) are at risk of progressive loss of kidney function, heart failure, and cardiovascular death despite current proven therapies, including renin-angiotensin system inhibitors (RASi), sodium glucose co-transporter-2 i ... Full text Cite

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Journal Article Nephrol Dial Transplant · April 1, 2025 BACKGROUND: Hyperuricaemia and gout are common in chronic kidney disease (CKD). We aimed to assess the effects of sodium-glucose co-transporter-2 (SGLT2) inhibition on uric acid (urate) and gout in patients with CKD. METHODS: The EMPA-KIDNEY trial randomis ... Full text Link to item Cite
View All Publications

Recent Grants


Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

EASi-KIDNEY: The Study of Heart and Kidney Protection with "BI 690517"

Clinical TrialPrincipal Investigator · Awarded by The Chancellor Masters and Scholars of the University of Oxford · 2023 - 2029

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) - Microbiome Collection

Clinical TrialPrincipal Investigator · Awarded by The George Washington University · 2012 - 2025

View All Grants

Education, Training & Certifications


University of Virginia · 1993 M.D.